Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome | Leukemia
How I treat older patients with acute myeloid leukemia
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes | Haematologica
SDRIFE Induced by Liposomal Daunorubicin and Cytarabine - Practical Dermatology
ARA-C RELATED RED EAR SYNDROME - Kamal Kant Sahu, Uday Yanamandra, Pankaj Malhotra, 2019
Generalized benign cutaneous reaction to cytarabine. | Semantic Scholar
Treatment of Leukemia with Low Dose Ara-C: A Study of 159 Cases *
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
What Is Cytarabine?
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
Cytosine Arabinoside-Induced Vasculitis
1930-R-MPV/high dose cytarabine overview | eviQ
Hematologic Malignancy for Internist 2014 Chinadol Wanitpongpun MD. - ppt download
ท่องโลกOnco - สวัสดียามดึกนะคะทุกคน... | Facebook
PDF) Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Hand-Foot Syndrome in a child treated with ara-C for AL | Download Scientific Diagram
PPT - BONE MARROW TRANSPLANT CHEMOTHERAPY PowerPoint Presentation, free download - ID:3258476
Canc2 | PPT
PPT - Introduction to Conventional Chemotherapy PowerPoint Presentation - ID:565085
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
ホーム｜造血器腫瘍診療ガイドライン 2018年版補訂版｜一般社団法人 日本血液学会
